URANIUM ENERGY CORP (UEC)

US9168961038 - Common Stock

7.08  -0.38 (-5.09%)

After market: 7.13 +0.05 (+0.71%)

Fundamental Rating

3

Overall UEC gets a fundamental rating of 3 out of 10. We evaluated UEC against 205 industry peers in the Oil, Gas & Consumable Fuels industry. While UEC has a great health rating, there are worries on its profitability. UEC does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

In the past year UEC has reported negative net income.
UEC had a negative operating cash flow in the past year.
In the past 5 years UEC reported 4 times negative net income.
In the past 5 years UEC reported 4 times negative operating cash flow.

1.2 Ratios

UEC's Return On Assets of -3.28% is on the low side compared to the rest of the industry. UEC is outperformed by 82.84% of its industry peers.
UEC's Return On Equity of -3.76% is on the low side compared to the rest of the industry. UEC is outperformed by 76.96% of its industry peers.
Industry RankSector Rank
ROA -3.28%
ROE -3.76%
ROIC N/A
ROA(3y)-0.75%
ROA(5y)-5.39%
ROE(3y)-0.89%
ROE(5y)-7.03%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of UEC (16.52%) is worse than 68.14% of its industry peers.
The Profit Margin and Operating Margin are not available for UEC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

UEC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for UEC has been increased compared to 1 year ago.
Compared to 5 years ago, UEC has more shares outstanding
There is no outstanding debt for UEC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

UEC has an Altman-Z score of 16.52. This indicates that UEC is financially healthy and has little risk of bankruptcy at the moment.
UEC has a better Altman-Z score (16.52) than 97.06% of its industry peers.
UEC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 16.52
ROIC/WACCN/A
WACC9.21%

2.3 Liquidity

UEC has a Current Ratio of 8.05. This indicates that UEC is financially healthy and has no problem in meeting its short term obligations.
UEC's Current ratio of 8.05 is amongst the best of the industry. UEC outperforms 92.65% of its industry peers.
A Quick Ratio of 5.46 indicates that UEC has no problem at all paying its short term obligations.
UEC has a Quick ratio of 5.46. This is amongst the best in the industry. UEC outperforms 89.71% of its industry peers.
Industry RankSector Rank
Current Ratio 8.05
Quick Ratio 5.46

3

3. Growth

3.1 Past

UEC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -300.00%.
The Revenue for UEC has decreased by -99.86% in the past year. This is quite bad
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
Revenue 1Y (TTM)-99.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

The Earnings Per Share is expected to grow by 52.74% on average over the next years. This is a very strong growth
UEC is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 50.57% yearly.
EPS Next Y108.41%
EPS Next 2Y178.29%
EPS Next 3Y71.34%
EPS Next 5Y52.74%
Revenue Next Year152.11%
Revenue Next 2Y107.76%
Revenue Next 3Y74.73%
Revenue Next 5Y50.57%

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UEC. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 2105.08, the valuation of UEC can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UEC indicates a slightly more expensive valuation: UEC is more expensive than 75.00% of the companies listed in the same industry.
UEC is valuated expensively when we compare the Price/Forward Earnings ratio to 22.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 2105.08

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates UEC does not grow enough to justify the current Price/Earnings ratio.
UEC's earnings are expected to grow with 71.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y178.29%
EPS Next 3Y71.34%

0

5. Dividend

5.1 Amount

No dividends for UEC!.
Industry RankSector Rank
Dividend Yield N/A

URANIUM ENERGY CORP

NYSEARCA:UEC (12/20/2024, 8:04:00 PM)

After market: 7.13 +0.05 (+0.71%)

7.08

-0.38 (-5.09%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)12-10 2024-12-10/bmo
Earnings (Next)N/A N/A
Inst Owners78.03%
Inst Owner Change3.13%
Ins Owners1.95%
Ins Owner Change5.34%
Market Cap3.00B
Analysts82
Price Target11.09 (56.64%)
Short Float %12.1%
Short Ratio5.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-467.55%
Min EPS beat(2)-595.05%
Max EPS beat(2)-340.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)0
Avg Revenue beat(4)-99.61%
Min Revenue beat(4)-100%
Max Revenue beat(4)-99.18%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.14%
PT rev (3m)10.97%
EPS NQ rev (1m)-84.09%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-92.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2105.08
P/S 13372.67
P/FCF N/A
P/OCF N/A
P/B 3.85
P/tB 13.58
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)0
Fwd EY0.05%
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0
BVpS1.84
TBVpS0.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.28%
ROE -3.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.52%
FCFM N/A
ROA(3y)-0.75%
ROA(5y)-5.39%
ROE(3y)-0.89%
ROE(5y)-7.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 286.86%
Cap/Sales 1530.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.05
Quick Ratio 5.46
Altman-Z 16.52
F-Score2
WACC9.21%
ROIC/WACCN/A
Cap/Depr(3y)135.76%
Cap/Depr(5y)103.6%
Cap/Sales(3y)511.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
EPS Next Y108.41%
EPS Next 2Y178.29%
EPS Next 3Y71.34%
EPS Next 5Y52.74%
Revenue 1Y (TTM)-99.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year152.11%
Revenue Next 2Y107.76%
Revenue Next 3Y74.73%
Revenue Next 5Y50.57%
EBIT growth 1Y-724.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.87%
EBIT Next 3Y50.45%
EBIT Next 5Y48.91%
FCF growth 1Y-252.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-246.73%
OCF growth 3YN/A
OCF growth 5YN/A